Great discussion [Design Issues]

posted by Ohlbe – France, 2020-01-02 17:57 (1894 d 05:57 ago) – Posting: # 21053
Views: 11,140

Dear ElMaestro,

❝ Can you guys think of any other biomarker/indicator unrelated to blood loss or the regenerative process?


Needle prick marks in the forearm veins, if the subject is so greedy (or hungry :-() that he does not even wait for them to heal ? Well, actually it would be relevant, if I am to believe Zeba Ziddiqui's paper which you mentioned earlier (with subjects participating in 3 or 4 trials in the same month). I never saw a protocol with a non-inclusion criterion "Subject with needle marks in the forearm". So I never saw a tick box anywhere in the screening documentation with this criterion.

I'm not aware of any other indicator, unfortunately.

By the way, I really don't see how a subject could participate in 3 or 4 trials in the same month without the CRO(s) being aware of it. I'm really not sure whether some of the CROs are really willing to know whether the subjects cross-participate.

[image] © Roberto Mangosi

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,406 posts in 4,919 threads, 1,724 registered users;
42 visitors (0 registered, 42 guests [including 9 identified bots]).
Forum time: 23:55 CET (Europe/Vienna)

No investigation can strictly be called scientific
unless it admits of mathematical demonstration.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5